November 21, 2017
3:00 pm / 4:00 pm Los Angeles
CLICK HERE TO REGISTER
You are invited to take part in a webinar introducing the HPTN SUSC (Substance Use Scientific Committee) SUMI (Substance Use Measure Identification) Tool. This webinar will take place on Tuesday, 21 November, at 12 noon PT / 3pm ET, and will provide an overview of the Committee’s new tool, which was recently launched on the HPTN website. The SUMI tool is a web-based, interactive tool to assist researchers to identify the proper biomarkers and behavioral survey tools to assess substance use in the HIV setting. Experts from different areas of the Network collaborated on the SUMI tool project.
Host: Gabriela Salinas-Jimenez
Speakers:
Steffanie Strathdee – Steffanie A. Strathdee, PhD, is the Associate Dean of Global Health Sciences and Harold Simon Professor in the Department of Medicine at the University of California San Diego School of Medicine. She is also an Adjunct Professor at the Johns Hopkins and Simon Fraser Universities. Dr. Strathdee is an infectious disease epidemiologist who has spent the last two decades focusing on HIV prevention in underserved, marginalized populations in developed and developing countries, including injection drug users, men having sex with men, and sex workers. Dr. Strathdee also serves as Chair of the HPTN Substance Use Scientific Committee.
Shipeng Chen – Shipeng Chen serves as a steering committee member in the HPTN Community Working Group (CWG) and representative for the HPTN Substance Use Scientific Committee. He designed and developed the SUMI application for the Committee. Shipeng is a physician specialized in transmission disease and has a masters degree in Public Health from Tulane University.
Steve Shoptaw – Steve Shoptaw, PhD, is Professor of Family Medicine at the David Geffen School of Medicine at UCLA. For the HPTN, Steve is a member of the Executive Committee and is liaison to the Substance Use Scientific Committee. Steve directs the UCLA Center for HIV Identification Prevention and Treatment Services and the UCLA Center for Behavioral and Addiction Medicine.